Knowing which risk factors are modifiable can help you make lifestyle changes to improve your chances ofremissionor disease-free survival.
The cancer stage helps directs the appropriatecourse of treatmentas well as predict the likely outcome (prognosis).
Stage 2 Survival Statistics
Cancer survival is typically described in terms of five-year survival rates.
Verywell / Emily Roberts
This is the percentage of people who live for at least five years following their diagnosis.
Epidemiologists and health authorities calculate survival in different ways.
Both methods have their advantages and disadvantages.
Survival rates like these are not carved in stone.
Some people can live well in excess of the five-year estimates, while others may fall short of them.
This is categorized in one of the following three ways.
One of the advantages of the SEER system is that it can be applied to both NSCLC and SCLC.
On the downside, there is a significant overlap in definitions.
On the other hand, stage 2b NSCLC is considered regional, since lymph nodes are involved.
As such, it falls into the same category asstage 3a NSCLC.
Multiple variables can influence five-year survival rates, some of which are modifiable and others of which are not.
Age
Survival times in people with NSCLC in general tend to decrease in tandem with advancing age.
This is in part because of diminishing overall health.
Over time, the disparity becomes even more apparent.
The ability to function in daily life with cancer is referred to asperformance status (PS).
This translates to a greater than 50% reduction in overall survival times for people with stage 2 NSCLC.
By contrast,quitting cigarettesincreases five-year survival rates to around 70% independent of all other risk factors.
punch in of Lung Cancer
Not all lung cancers are the same.
The following are the three most common types.
punch in of Surgery
Lung cancer surgery is a mainstay of treatment for stage 2 NSCLC.
As a general rule, survival rates tend to decrease in tandem with the amount of lung tissue removed.
This is especially true when comparing lobectomy to pneumonectomy.
Early diagnosis is key to improving outcomes.
2017;9(6):269-79. doi:10.4329/wjr.v9.i6.269
National Cancer Institute.Cancer staging.
National Cancer Institute.Non-small cell lung cancer treatment (PDQ)health professional version.
National Organization for Rare Disorders.Small cell lung cancer.
American Cance Society.Key statistics for lung cancer.
Cancer Research UK.Lung cancer survival statistics.
2019;11:943-53. doi:10.2147/CMAR.S187317
American Cancer Society.Surgery for non-small cell lung cancer.
